Deals
Bio-Rad Rises on Bet Family May Seek Sale: San Francisco Mover
This article is for subscribers only.
Bio-Rad Laboratories Inc., a maker of medical screening and research equipment, rose the most in more than three years on speculation the family-run company may be open to a sale after the death of its founder.
Bio-Rad jumped 11 percent to $114.25 in New York, its biggest percentage gain since November 2008. It has a market value of about $3.2 billion.